SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-20-003577
Filing Date
2020-02-13
Accepted
2020-02-13 16:16:20
Documents
50
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q1219_citiuspharmaceutic.htm 10-Q 268072
2 FORM OF NOTICE OF STOCK OPTION GRANT AND STOCK OPTION AWARD AGREEMENT f10q1219ex10-2_citiuspharma.htm EX-10.2 89668
3 CERTIFICATION f10q1219ex31-1_citiuspharma.htm EX-31.1 10519
4 CERTIFICATION f10q1219ex31-2_citiuspharma.htm EX-31.2 10463
5 CERTIFICATIONS f10q1219ex32-1_citiuspharma.htm EX-32.1 4802
  Complete submission text file 0001213900-20-003577.txt   2416346

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE ctxr-20191231.xml EX-101.INS 314175
7 XBRL SCHEMA FILE ctxr-20191231.xsd EX-101.SCH 40780
8 XBRL CALCULATION FILE ctxr-20191231_cal.xml EX-101.CAL 35342
9 XBRL DEFINITION FILE ctxr-20191231_def.xml EX-101.DEF 127555
10 XBRL LABEL FILE ctxr-20191231_lab.xml EX-101.LAB 268429
11 XBRL PRESENTATION FILE ctxr-20191231_pre.xml EX-101.PRE 203747
Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

IRS No.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-38174 | Film No.: 20610754
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences